Stargardt Disease Clinical Trials 2022

Browse 19 Stargardt Disease Medical Studies Across 131 Cities

3 Phase 3 Trial · 218 Stargardt Disease Clinics

Reviewed by Michael Gill, B. Sc.
19 Stargardt Disease Clinical Trials Near Me
Fullerton, CA
Dallas, TX
Birmingham, AL
Birmingham, AL
More Trial Locations
An interactive map to display trial locations for Retina Consultants of Orange County, Retina Foundation of the Southwest, UAB, Nanoscope Clinical Site, and 179 more locations.
Most Popular References for Stargardt Disease Clinical Trials
Frequency
Citation
Top Hospitals for Stargardt Disease Clinical Trials
Location
Active Stargardt Disease Clinical Trials
All Time Trials for Stargardt Disease
First Recorded Stargardt Disease Trial
Trials
Retina Center of New Jersey, LLC, Bloomfield, New Jersey
3
6
2014
Florida Eye Associates, Melbourne, Florida
2
20
2014
Top Treatments for Stargardt Disease Clinical Trials
Treatment Name
Active Stargardt Disease Clinical Trials
All Time Trials for Stargardt Disease
First Recorded Stargardt Disease Trial
Trials
Avacincaptad pegol 2 mg intravitreal injection
1
1
2022
Top Cities for Stargardt Disease Clinical Trials
City
Active Stargardt Disease Clinical Trials
Top Active Site for Stargardt Disease Clinical Trials
Trial List
Bloomfield, New Jersey
5
Retina Center of New Jersey, LLC
Philadelphia, Pennsylvania
5
Mid Atlantic Retina
Phase 3 Stargardt Disease Clinical Trials
Pediatric Stargardt Disease Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Stargardt Disease
Treatment
Year
Mechanism of Action
Sponsor
Active Stargardt Disease Clinical Trials
RBM-007 Injectable Solution
2021
Maturi, Raj K., M.D., P.C.
0
EYP-1901
2021
EyePoint Pharmaceuticals, Inc.
0
GEM103
2020
Gemini Therapeutics, Inc.
0
MHU650
2020
Novartis Pharmaceuticals
0
RBM-007
2020
Ribomic USA Inc
0
UBX1325
2020
Unity Biotechnology, Inc.
0
SB15 (Proposed aflibercept biosimilar)
2020
Aflibercept
Samsung Bioepis Co., Ltd.
0
AR-13503 63.6 Dose
2019
Aerie Pharmaceuticals
0
Subcutaneous elamipretide through the elamipretide delivery system
2019
Elamipretide
Stealth BioTherapeutics Inc.
0
Faricimab
2019
Faricimab
Hoffmann-La Roche
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 27th, 2021

Last Reviewed: August 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.